Abstract | OBJECTIVE: To investigate the potential effect of EBB, a calmodulin antagonist, on invasion of human fibrosarcoma cells HT1080. METHODS: RESULTS:
Calmodulin antagonist EBB inhibited the proliferation of HT1080 cells with an IC50 of (8.2 +/- 1.2) microg/ml. EBB down-regulated the activities of MMP-2 and MMP-9, and down-regulated the mRNA levels of MMP-2 and MMP-9, while up-regulated the mRNA levels of TIMP-1. The invasive ability of HT1080 cells was decreased to (31.13 +/- 2.265)%, (59.91 +/- 2.566)%, and (71.58 +/- 0.5960)% after exposure of the cells with 2, 5, and 10 microg/ml EBB, respectively. CONCLUSION: Treatment with calmodulin antagonist EBB is effective in suppressing tumor invasion. The possible mechanism is the down-regulation of MMPs.
|
Authors | Bing Pan, Yuan Zhou, Jing Qi, Dong-sheng Xiong, Jie-wen Liu, Shu-ling Qi, Yan-hong Cheng, Chun-zheng Yang, Hui-fang Zhu |
Journal | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
(Zhongguo Yi Xue Ke Xue Yuan Xue Bao)
Vol. 27
Issue 3
Pg. 311-4
(Jun 2005)
ISSN: 1000-503X [Print] China |
PMID | 16038266
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Benzylisoquinolines
- Calmodulin
- RNA, Messenger
- O-(4-ethoxybutyl)berbamine
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Benzylisoquinolines
(pharmacology)
- Calmodulin
(antagonists & inhibitors)
- Cell Line, Tumor
- Down-Regulation
- Fibrosarcoma
(pathology)
- Humans
- Matrix Metalloproteinase 2
(biosynthesis, genetics)
- Matrix Metalloproteinase 9
(biosynthesis, genetics)
- Neoplasm Invasiveness
- RNA, Messenger
(biosynthesis, genetics)
|